Bid, H. K., Kibler, A., Phelps, D. A., Manap, S., Xiao, L., Lin, J., . . . Houghton, P. J. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma.
Dyfyniad Arddull ChicagoBid, Hemant K., et al. Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. 2013.
Dyfyniad MLABid, Hemant K., et al. Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.